Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer

BACKGROUND: While epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) exert a breakthrough effect, the incidence of skin disorders as a side effect has significantly reduced patients’ quality of life. This study aimed to develop a treatment for inflammatory ulcers as one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sano, Kazumi, Nakadate, Kazuhiko, Hanada, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137492/
https://www.ncbi.nlm.nih.gov/pubmed/32252690
http://dx.doi.org/10.1186/s12885-020-06797-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137492/
https://www.ncbi.nlm.nih.gov/pubmed/32252690
http://dx.doi.org/10.1186/s12885-020-06797-2

Ejemplares similares